Latest Insider Transactions at Sage Therapeutics, Inc. (SAGE)
This section provides a real-time view of insider transactions for Sage Therapeutics, Inc. (SAGE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sage Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sage Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 22
2021
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+4.75%
|
$2,500
$1.36 P/Share
|
|
Nov 09
2021
|
Steven M Paul |
BUY
Other acquisition or disposition
|
Indirect |
1
+50.0%
|
$43
$43.36 P/Share
|
|
Oct 19
2021
|
Stephen Kanes Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,120
-7.68%
|
$44,800
$40.29 P/Share
|
|
Oct 19
2021
|
Stephen Kanes Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,800
+20.66%
|
-
|
|
Oct 19
2021
|
Jeffrey M Jonas |
SELL
Payment of exercise price or tax liability
|
Direct |
4,374
-5.13%
|
$174,960
$40.29 P/Share
|
|
Oct 19
2021
|
Jeffrey M Jonas |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+10.5%
|
-
|
|
Oct 19
2021
|
Anne Marie Cook SVP, GC & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,116
-12.39%
|
$44,640
$40.29 P/Share
|
|
Oct 19
2021
|
Anne Marie Cook SVP, GC & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
3,800
+29.66%
|
-
|
|
Oct 19
2021
|
Albert Robichaud Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,116
-0.78%
|
$44,640
$40.29 P/Share
|
|
Oct 19
2021
|
Albert Robichaud Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,800
+2.58%
|
-
|
|
Oct 19
2021
|
Kimi Iguchi CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,024
-2.11%
|
$40,960
$40.29 P/Share
|
|
Oct 19
2021
|
Kimi Iguchi CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
3,800
+7.25%
|
-
|
|
Aug 05
2021
|
Barry E Greene President and CEO |
BUY
Open market or private purchase
|
Direct |
23,640
+42.15%
|
$1,016,520
$43.15 P/Share
|
|
Jun 16
2021
|
Barry E Greene President and CEO |
BUY
Open market or private purchase
|
Direct |
8,800
+50.0%
|
$492,800
$56.32 P/Share
|
|
Jun 16
2021
|
Kevin P Starr |
BUY
Open market or private purchase
|
Direct |
17,842
+5.27%
|
$999,152
$56.05 P/Share
|
|
Jun 16
2021
|
James M Frates |
BUY
Open market or private purchase
|
Indirect |
1,810
+50.0%
|
$99,550
$55.1 P/Share
|
|
Jun 16
2021
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+4.3%
|
$2,000
$1.36 P/Share
|
|
Jun 16
2021
|
Jeffrey M Jonas |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+13.76%
|
$0
$0.45 P/Share
|
|
Jun 15
2021
|
Kimi Iguchi CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
822
-1.9%
|
$47,676
$58.8 P/Share
|
|
Jun 15
2021
|
Kimi Iguchi CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
3,500
+7.47%
|
-
|
|
Jun 15
2021
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+7.0%
|
$3,000
$1.36 P/Share
|
|
Jun 15
2021
|
Stephen Kanes Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,001
-8.49%
|
$58,058
$58.8 P/Share
|
|
Jun 15
2021
|
Stephen Kanes Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,500
+22.89%
|
-
|
|
Jun 15
2021
|
Albert Robichaud Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,144
-0.81%
|
$66,352
$58.8 P/Share
|
|
Jun 15
2021
|
Albert Robichaud Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+2.76%
|
-
|
|
Jun 15
2021
|
Jeffrey M Jonas |
SELL
Payment of exercise price or tax liability
|
Direct |
3,093
-4.66%
|
$179,394
$58.8 P/Share
|
|
Jun 15
2021
|
Jeffrey M Jonas |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+13.1%
|
-
|
|
Jun 15
2021
|
Anne Marie Cook SVP, GC & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,144
-18.7%
|
$66,352
$58.8 P/Share
|
|
Jun 15
2021
|
Anne Marie Cook SVP, GC & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+39.54%
|
-
|
|
Apr 13
2021
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+3.91%
|
$1,500
$1.36 P/Share
|
|
Jan 27
2021
|
Jeffrey M Jonas |
BUY
Exercise of conversion of derivative security
|
Direct |
1,800
+3.1%
|
$0
$0.45 P/Share
|
|
Jan 05
2021
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+4.72%
|
$1,750
$1.36 P/Share
|